Centessa Pharmaceuticals plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Centessa Pharmaceuticals plc - ADR: Is Infosys Ltd. worth buying?
Item: Centessa Pharmaceuticals plc - ADR
Rating: 1.56350
Author: Trendlyne DVM scores

about

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arter...

16.56 -0.09 (-0.54%)

72.50% Gain from 52W Low

389.2K

XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.0 / 100

Technically Neutral

56.5 / 100

1Yr Price target upside is 83%

7 analysts

Centessa Pharmaceuticals p... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Centessa Pharmaceuticals plc - ADR Live Stock Price Today, Share Analysis and Chart

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arter...

72.50% Gain from 52W Low

SWOT Analysis

Centessa Pharmaceuticals p... Live Price Chart